Electronically Recorded National Early Warning Scores, Pain Scores and PONV Scores Among Hospitalized Patients

December 5, 2021 updated by: Joonas Tirkkonen, Tampere University Hospital

Electronically Recorded National Early Warning Scores, Pain Scores and PONV Scores Among Hospitalized Patients and the Associated Patient Outcomes.

National early warning score (NEWS) enables early detection of patient deterioration in hospital floors. However, there is limited data on the prognostic value of NEWS among actual general ward patients. Further, there is no data on how changes in NEWS-values impact patient outcomes. Very little is known on how post-operative nausea and vomiting (PONV) and pain influences NEWS values and vital signs in general.

Study Overview

Status

Active, not recruiting

Detailed Description

The investigators aim to collect detailed data on patients' vital signs, NEWSs, pain scores and PONV scores through electronic data records, where these values are automatically stored with mobile mobile smart devices used by nursing staff. The expected volume of the cohort is 50,000 patients and 300,000 recordings of vital signs.

In addition to the scores and vital signs, the registry will include patients' identification numbers (IDs), dates and times of the recordings, and ward numbers. With the IDs, mortality data up to 90-days for the patients will be obtained from the national population register centre. All data will be handled in a pseudonymized form in a secure computer inside hospital, and approval to use the registry in study purposes will be obtained from the Ethics Committee of Tampere University Hospital.

Study Type

Observational

Enrollment (Actual)

30000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Pirkanmaa
      • Tampere, Pirkanmaa, Finland, 33520
        • Tampere University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Adult in-hospital patients in Pirkanmaa Hospital District whose vital signs have been recorded with mobile smart devices during the study period.

Description

Inclusion Criteria:

  • Adult in-hospital patients with recordings of vital signs

Exclusion Criteria:

  • Patients under 18 years

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Death occurring within 90-days of the last NEWS measurement
Time Frame: 90 days
The percentage of patients that die within 90-days of the last NEWS recording during their hospitalization.
90 days
Death occurring within one day after the first NEWS measurement on general wards
Time Frame: One day
The percentage of patients that die within one day after their first NEWS measurement at the beginning of their general ward admission
One day

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Death occurring within 30-days of the last NEWS measurement
Time Frame: 30 days
The percentage of patients that die within 30-days of the last NEWS recording during their hospitalization.
30 days
Death occurring within 2-30 days after the first NEWS measurement on general wards
Time Frame: 2-30 days
The percentage of patients that die within 2-30 days after their first NEWS measurement at the beginning of their general ward admission
2-30 days
Incidence of post operative nausea and vomiting
Time Frame: Up to 30 days after the first recording of patient's vital signs in the electronic patient records
Percentage of patients suffering from post-operative nausea and vomiting (recorded as a scale from 0 to 5) in the electronic patient records.
Up to 30 days after the first recording of patient's vital signs in the electronic patient records
Incidence of post operative pain
Time Frame: Up to 30 days after the first recording of patient's vital signs in the electronic patient records
Percentage of patients suffering from post operative pain (recorded as numerical scale from 0 to 10) in the electronic patient records.
Up to 30 days after the first recording of patient's vital signs in the electronic patient records

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2019

Primary Completion (Actual)

December 31, 2019

Study Completion (Anticipated)

June 30, 2022

Study Registration Dates

First Submitted

August 5, 2019

First Submitted That Met QC Criteria

August 12, 2019

First Posted (Actual)

August 13, 2019

Study Record Updates

Last Update Posted (Actual)

December 21, 2021

Last Update Submitted That Met QC Criteria

December 5, 2021

Last Verified

December 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Due to data security policies, individual participant data will not be shared.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Prevention of In-hospital Adverse Events

3
Subscribe